Annual report
177A.TEDINET S100YB5D
Period2025-04-01 → 2026-03-31
Filed2026-06-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.9bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥5.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥4.8bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.7bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.9bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥342m | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥991m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥341m | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥636m | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥918m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥332m | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.0bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥251m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥795m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥385m | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥830m | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥588m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥251m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥795m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥8.9bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥9.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥6.6bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥6.1bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥5.6bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.0bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥3.3bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥5.9bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.8bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.3bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥3.0bn | at 2023-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥2.2bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.5bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.1bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.5bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2023-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.7bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥699m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥916m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥824m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥461m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥763m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥868m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥577m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥575m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥83m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥321m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥172m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥360m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥49.11 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥157.57 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥92.43 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥199.23 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥173.5 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,163.08 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,131.12 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥802.5 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥724.57 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥532.27 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 66.8% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.7% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.2% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.6% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 4.3% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.4% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.1% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 31.7% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 31.2% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 176 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 167 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 159 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 139 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 130 | at 2022-03-31d | Cons. | Number of employees |
| Revenue | ¥4.2bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥4.6bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥4.4bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.4bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.6bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥58m | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥727m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥72m | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥703m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥409m | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥842m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥70m | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥661m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥63m | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥509m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥212m | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥751m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥564m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥7.7bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥8.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥6.0bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥5.8bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥5.3bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.8bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥3.1bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥4.9bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥5.0bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.8bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥2.7bn | at 2023-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥2.0bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.5bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.5bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥12.27 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥100.93 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.9 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥180.37 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥166.59 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥10 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥100 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥957.02 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥968.65 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥683.18 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥651.21 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥480.9 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 63.9% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.6% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.2% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.2% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.0% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 1.3% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.1% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 31.9% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 33.2% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 5,111,600 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,111,600 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,165,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,165,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 416,500 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 150 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 141 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 135 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 117 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 108 | at 2022-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 42
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2025-04-01 → 2026-03-31 | ¥70m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥590m |
| Cell Process Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥113m |
| Cell Process Businessreportable segment | employees | at 2026-03-31 | 48 pure |
| Cell Process Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥975m |
| Cell Process Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥975m |
| Cell Process Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥80m |
| Microbiological Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥137m |
| Microbiological Businessreportable segment | employees | at 2026-03-31 | 54 pure |
| Microbiological Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥1.4bn |
| Microbiological Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥1.4bn |
| Microbiological Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥95m |
| Tissue Culture Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥74m |
| Tissue Culture Businessreportable segment | employees | at 2026-03-31 | 61 pure |
| Tissue Culture Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥2.5bn |
| Tissue Culture Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥2.5bn |
| Tissue Culture Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥946m |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥325m |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥4.9bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥4.9bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥932m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥16m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥528m |
| Cell Process Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥130m |
| Cell Process Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Cell Process Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Cell Process Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥313m |
| Microbiological Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥131m |
| Microbiological Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.8bn |
| Microbiological Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.8bn |
| Microbiological Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥441m |
| Tissue Culture Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥83m |
| Tissue Culture Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥2.3bn |
| Tissue Culture Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥2.3bn |
| Tissue Culture Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥765m |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥344m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥5.2bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥5.2bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥1.5bn |
| Cell Process Businessreportable segment | employees | at 2026-03-31 | 48 pure |
| Microbiological Businessreportable segment | employees | at 2026-03-31 | 49 pure |
| Tissue Culture Businessreportable segment | employees | at 2026-03-31 | 40 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,479
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | Prior4YearInstant | 5595281000 | JPY |
| Total assets (5-year summary) | Prior3YearInstant | 6134824000 | JPY |
| Total assets (5-year summary) | Prior2YearInstant | 6589322000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 9066648000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant | 8904397000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 532.27 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 724.57 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 802.50 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 1131.12 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 1163.08 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 173.50 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 199.23 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 92.43 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 157.57 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 49.11 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.396 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.492 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.507 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.638 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.668 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | 0.312 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | 0.317 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.121 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.174 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.043 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 11.1 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 24.6 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | 762981000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | 461153000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | 823681000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 915551000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 698508000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | 82780000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -575459000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -577354000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -1090901000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -867672000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | -360174000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | -172209000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | -1348000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 1376032000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | -320756000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |